377 related articles for article (PubMed ID: 32138190)
21. Therapeutic targets of cancer drugs: Modulation by melatonin.
Moloudizargari M; Moradkhani F; Hekmatirad S; Fallah M; Asghari MH; Reiter RJ
Life Sci; 2021 Feb; 267():118934. PubMed ID: 33385405
[TBL] [Abstract][Full Text] [Related]
22. Withaferin A and its potential role in glioblastoma (GBM).
Dhami J; Chang E; Gambhir SS
J Neurooncol; 2017 Jan; 131(2):201-211. PubMed ID: 27837436
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of ERK1/2 Signaling Pathway is Involved in Melatonin's Antiproliferative Effect on Human MG-63 Osteosarcoma Cells.
Liu L; Xu Y; Reiter RJ; Pan Y; Chen D; Liu Y; Pu X; Jiang L; Li Z
Cell Physiol Biochem; 2016; 39(6):2297-2307. PubMed ID: 27832629
[TBL] [Abstract][Full Text] [Related]
24. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal.
Blask DE; Dauchy RT; Sauer LA
Endocrine; 2005 Jul; 27(2):179-88. PubMed ID: 16217131
[TBL] [Abstract][Full Text] [Related]
25. The potential therapeutic actions of melatonin in colorectal cancer.
Chok KC; Ng CH; Koh RY; Ng KY; Chye SM
Horm Mol Biol Clin Investig; 2019 May; 39(1):. PubMed ID: 31141480
[TBL] [Abstract][Full Text] [Related]
26. Glioblastoma: Role of Mitochondria N-acetylserotonin/Melatonin Ratio in Mediating Effects of miR-451 and Aryl Hydrocarbon Receptor and in Coordinating Wider Biochemical Changes.
Anderson G; Reiter RJ
Int J Tryptophan Res; 2019; 12():1178646919855942. PubMed ID: 31244524
[TBL] [Abstract][Full Text] [Related]
27. Evidence for the efficacy of disulfiram and copper combination in glioblastoma multiforme - A propos of a case.
Karamanakos PN; Trafalis DT; Papachristou DJ; Panteli ES; Papavasilopoulou M; Karatzas A; Kardamakis D; Nasioulas G; Marselos M
J BUON; 2017; 22(5):1227-1232. PubMed ID: 29135106
[TBL] [Abstract][Full Text] [Related]
28. Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment.
Ganipineni LP; Danhier F; Préat V
J Control Release; 2018 Jul; 281():42-57. PubMed ID: 29753958
[TBL] [Abstract][Full Text] [Related]
29. Particular phosphorylation of PI3K/Akt on Thr308 via PDK-1 and PTEN mediates melatonin's neuroprotective activity after focal cerebral ischemia in mice.
Kilic U; Caglayan AB; Beker MC; Gunal MY; Caglayan B; Yalcin E; Kelestemur T; Gundogdu RZ; Yulug B; Yılmaz B; Kerman BE; Kilic E
Redox Biol; 2017 Aug; 12():657-665. PubMed ID: 28395173
[TBL] [Abstract][Full Text] [Related]
30. The Therapeutic Potential of Melatonin in Alzheimer's Disease: A Comprehensive Review.
Zhang J; Feng M; Kong L
Curr Med Chem; 2024 Mar; ():. PubMed ID: 38561619
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of TFEB oligomerization by co-treatment of melatonin with vorinostat promotes the therapeutic sensitivity in glioblastoma and glioma stem cells.
Sung GJ; Kim SH; Kwak S; Park SH; Song JH; Jung JH; Kim H; Choi KC
J Pineal Res; 2019 Apr; 66(3):e12556. PubMed ID: 30648757
[TBL] [Abstract][Full Text] [Related]
32. Effects of the pineal hormone melatonin on the anchorage-independent growth of human breast cancer cells (MCF-7) in a clonogenic culture system.
Cos S; Blask DE
Cancer Lett; 1990 Apr; 50(2):115-9. PubMed ID: 2328480
[TBL] [Abstract][Full Text] [Related]
33. Therapy for glioblastoma: is it working?
Zanders ED; Svensson F; Bailey DS
Drug Discov Today; 2019 May; 24(5):1193-1201. PubMed ID: 30878561
[TBL] [Abstract][Full Text] [Related]
34. Advances in histone deacetylase inhibitors in targeting glioblastoma stem cells.
Reddy RG; Bhat UA; Chakravarty S; Kumar A
Cancer Chemother Pharmacol; 2020 Aug; 86(2):165-179. PubMed ID: 32638092
[TBL] [Abstract][Full Text] [Related]
35. Melatonin's role in preventing toxin-related and sepsis-mediated hepatic damage: A review.
Esteban-Zubero E; Alatorre-Jiménez MA; López-Pingarrón L; Reyes-Gonzales MC; Almeida-Souza P; Cantín-Golet A; Ruiz-Ruiz FJ; Tan DX; García JJ; Reiter RJ
Pharmacol Res; 2016 Mar; 105():108-20. PubMed ID: 26808084
[TBL] [Abstract][Full Text] [Related]
36. Neurobiological effects of melatonin as related to cancer.
Hoang BX; Shaw DG; Pham PT; Levine SA
Eur J Cancer Prev; 2007 Dec; 16(6):511-6. PubMed ID: 18090123
[TBL] [Abstract][Full Text] [Related]
37. Drug resistance in glioblastoma and cytotoxicity of seaweed compounds, alone and in combination with anticancer drugs: A mini review.
Ferreira J; Ramos AA; Almeida T; Azqueta A; Rocha E
Phytomedicine; 2018 Sep; 48():84-93. PubMed ID: 30195884
[TBL] [Abstract][Full Text] [Related]
38. Melatonin therapy for REM sleep behavior disorder: a critical review of evidence.
McGrane IR; Leung JG; St Louis EK; Boeve BF
Sleep Med; 2015 Jan; 16(1):19-26. PubMed ID: 25454845
[TBL] [Abstract][Full Text] [Related]
39. Use of nanoparticles for glioblastoma treatment: a new approach.
Játiva P; Ceña V
Nanomedicine (Lond); 2017 Oct; 12(20):2533-2554. PubMed ID: 28952878
[TBL] [Abstract][Full Text] [Related]
40. Melatonin for prevention of erythema and oxidative stress in response to ultraviolet radiation.
Scheuer C
Dan Med J; 2017 Jun; 64(6):. PubMed ID: 28566124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
